UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

A Review of mTOR Pathway Inhibitors in Gynecologic Cancer

Oxidative medicine and cellular longevity, 2017-01, Vol.2017 (1), p.4809751-4809751

2017

Volltextzugriff (PDF)

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

Cancer chemotherapy and pharmacology, 2015-02, Vol.75 (2), p.221-234

2015

Volltextzugriff (PDF)

Patterns of Care and Outcome of Elderly Women Diagnosed With Cervical Cancer in the Developing World

International journal of gynecological cancer, 2016-09, Vol.26 (7), p.1246-1251

2016

Volltextzugriff (PDF)

First-Line Paclitaxel and Carboplatin in Persistent/Recurrent or Advanced Cervical Cancer: A Retrospective Analysis of Patients Treated at Brazilian National Cancer Institute

International journal of gynecological cancer, 2013-05, Vol.23 (4), p.743-748

2013

Volltextzugriff (PDF)

Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)

Medical oncology (Northwood, London, England), 2018-03, Vol.35 (3), p.20-5, Article 20

2018

Volltextzugriff (PDF)

An investigator-initiated phase I study of ONX-0801, a first-in-class alpha folate receptor targeted, small molecule thymidylate synthase inhibitor in solid tumors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2503-2503

2017

Volltextzugriff (PDF)

Radiotherapy alone in locally advanced cervical cancer: a palliative treatment? Real-world data

Brazilian Journal of Oncology, 2021-10, Vol.17

2021

Volltextzugriff (PDF)

A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I

Cancer chemotherapy and pharmacology, 2016-07, Vol.78 (1), p.101-109

2016

Volltextzugriff (PDF)

A phase I study of oral SRA737 (formerly CCT245737) given in combination with gemcitabine plus cisplatin or gemcitabine alone in patients with advanced cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS2613-TPS2613

2017

Volltextzugriff (PDF)

A phase I study of SRA737 (formerly known as CCT245737) administered orally in patients with advanced cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS2607-TPS2607

2017

Volltextzugriff (PDF)

Prevalence and risk factors of HBV, HCV and HIV infections among cervical cancer patients in a tertiary care institution in Brazil

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e17009-e17009

2016

Volltextzugriff (PDF)

Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2542-2542

2017

Volltextzugriff (PDF)

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2530-2530

2018

Volltextzugriff (PDF)

Phase 1/2a trial of daily oral BAL101553, a novel tumor checkpoint controller (TCC), in advanced solid tumors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2532-2532

2017

Volltextzugriff (PDF)

Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22222-e22222

2015

Volltextzugriff (PDF)

Thromboembolic events in breast cancer patients: A large series

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9589-9589

2013

Volltextzugriff (PDF)

Topotecan Use for Second-Line Treatment in Patients with Recurrent or Metastatic Cervical Cancer at Brazilian National Cancer Institute (INCA)

Journal of cancer therapy, 2013, Vol.4 (6), p.1095-1099

2013

Volltextzugriff (PDF)

Approach and Management of Cervical Cancer

International Manual of Oncology Practice, p.491-549

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)
Buchkapitel
(1)

Sprache

Englisch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Female
(6)
Humans
(6)
Life Sciences & Biomedicine
(6)
Oncology
(6)
Science & Technology
(6)
Middle Aged
(4)
Adult
(3)
Aged
(3)
Cancer Research
(3)
Cervical Cancer
(3)
Medicine
(3)
Medicine & Public Health
(3)
Radiotherapy
(3)
Retrospective Studies
(3)
Aged, 80 And Over
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Follow-Up Studies
(2)
Neoplasm Recurrence, Local - Drug Therapy
(2)
Obstetrics & Gynecology
(2)
Palliative Chemotherapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Review of mTOR Pathway Inhibitors in Gynecologic Cancer

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

Patterns of Care and Outcome of Elderly Women Diagnosed With Cervical Cancer in the Developing World

First-Line Paclitaxel and Carboplatin in Persistent/Recurrent or Advanced Cervical Cancer: A Retrospective Analysis of Patients Treated at Brazilian National Cancer Institute

Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)

An investigator-initiated phase I study of ONX-0801, a first-in-class alpha folate receptor targeted, small molecule thymidylate synthase inhibitor in solid tumors

Radiotherapy alone in locally advanced cervical cancer: a palliative treatment? Real-world data

A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I

A phase I study of oral SRA737 (formerly CCT245737) given in combination with gemcitabine plus cisplatin or gemcitabine alone in patients with advanced cancer

A phase I study of SRA737 (formerly known as CCT245737) administered orally in patients with advanced cancer

Prevalence and risk factors of HBV, HCV and HIV infections among cervical cancer patients in a tertiary care institution in Brazil

Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors

A phase I study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma

Phase 1/2a trial of daily oral BAL101553, a novel tumor checkpoint controller (TCC), in advanced solid tumors

Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma

Thromboembolic events in breast cancer patients: A large series

Topotecan Use for Second-Line Treatment in Patients with Recurrent or Metastatic Cervical Cancer at Brazilian National Cancer Institute (INCA)

Approach and Management of Cervical Cancer

Suchergebnisse filtern